» Articles » PMID: 12050154

Mutated Human SOD1 Causes Dysfunction of Oxidative Phosphorylation in Mitochondria of Transgenic Mice

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2002 Jun 7
PMID 12050154
Citations 264
Authors
Affiliations
Soon will be listed here.
Abstract

A growing body of evidence suggests that impaired mitochondrial energy production and increased oxidative radical damage to the mitochondria could be causally involved in motor neuron death in amyotrophic lateral sclerosis (ALS) and in familial ALS associated with mutations of Cu,Zn superoxide dismutase (SOD1). For example, morphologically abnormal mitochondria and impaired mitochondrial histoenzymatic respiratory chain activities have been described in motor neurons of patients with sporadic ALS. To investigate further the role of mitochondrial alterations in the pathogenesis of ALS, we studied mitochondria from transgenic mice expressing wild type and G93A mutated hSOD1. We found that a significant proportion of enzymatically active SOD1 was localized in the intermembrane space of mitochondria. Mitochondrial respiration, electron transfer chain, and ATP synthesis were severely defective in G93A mice at the time of onset of the disease. We also found evidence of oxidative damage to mitochondrial proteins and lipids. On the other hand, presymptomatic G93A transgenic mice and mice expressing the wild type form of hSOD1 did not show significant mitochondrial abnormalities. Our findings suggest that G93A-mutated hSOD1 in mitochondria may cause mitochondrial defects, which contribute to precipitating the neurodegenerative process in motor neurons.

Citing Articles

Parkinson-like wild-type superoxide dismutase 1 pathology induces nigral dopamine neuron degeneration in a novel murine model.

Abdeen A, Trist B, Nikseresht S, Harwood R, Roudeau S, Rowlands B Acta Neuropathol. 2025; 149(1):22.

PMID: 40042537 PMC: 11882636. DOI: 10.1007/s00401-025-02859-6.


Oxidative stress induced protein aggregation via GGCT produced pyroglutamic acid in drug resistant glioblastoma.

Tiek D, Song X, Yu X, Wu R, Iglesia R, Catezone A iScience. 2025; 28(2):111769.

PMID: 39949960 PMC: 11821397. DOI: 10.1016/j.isci.2025.111769.


Targeting common disease pathomechanisms to treat amyotrophic lateral sclerosis.

Faller K, Chaytow H, Gillingwater T Nat Rev Neurol. 2025; 21(2):86-102.

PMID: 39743546 DOI: 10.1038/s41582-024-01049-4.


The Neuroprotective Effect of the X Protein of Orthobornavirus Bornaense Type 1 in Amyotrophic Lateral Sclerosis.

Tournezy J, Leger C, Klonjkowski B, Gonzalez-Dunia D, Szelechowski M, Garenne A Int J Mol Sci. 2024; 25(23).

PMID: 39684507 PMC: 11641280. DOI: 10.3390/ijms252312789.


AAV-mediated upregulation of VDAC1 rescues the mitochondrial respiration and sirtuins expression in a SOD1 mouse model of inherited ALS.

Magri A, Lipari C, Caccamo A, Battiato G, Conti Nibali S, De Pinto V Cell Death Discov. 2024; 10(1):178.

PMID: 38627359 PMC: 11021507. DOI: 10.1038/s41420-024-01949-w.